The aim of this study was to characterize differences in health-related quality of life among women presenting for treatment of fecal incontinence.
F ecal incontinence (FI) is defined as the involuntary loss of solid or liquid feces that is a social or hygienic problem. 1 When analyzing the prevalence of at least monthly FI among community-dwelling women in the United States, rates range from 3% to 22%, with older women consistently experiencing more FI than younger age groups. [2] [3] [4] [5] [6] [7] [8] Given the projected 38% increase in women aged 65 and older among the US population in the next few decades, more information is needed regarding differences in women presenting for FI treatment and the impact on quality of life (QOL). 9 FI has a significant negative impact on QOL among women, 10 -14 with few studies examining factors that impact QOL in women presenting for treatment. 13 FI may be associated with prior trauma to the external sphincter (obstetric or prior sphincter surgery), alterations in rectal capacity and compliance, bowel symptoms such as urgency and frequency, and age-related thinning in the external anal sphincter and other pelvic muscles. Medical conditions or comorbidities, such as diabetes, vascular disease, obesity, and neurologic diseases, are also independently associated with FI. [5] [6] [7] 10 Existing studies have examined differences in women presenting for FI treatment, but few have controlled for medical conditions and for patientcentered outcomes, such as severity, on QOL. 13 Given the paucity of data on QOL differences seen in women with FI, this study provides additional data on factors that may impact QOL in women presenting for FI treatment in a specialty-based clinic. After controlling for patient age and the severity of FI, we hypothesized that women presenting for FI treatment would have a greater negative impact on condition-specific QOL if they had more medical comorbidities, prior trauma to the external sphincter, and increased bowel symptoms.
METHODS Participants
Participants included women who presented with a primary symptom of fecal incontinence to the Genito-Rectal Disorders Clinic at the University of Alabama at Birmingham (UAB) since 2003. All women provided written consent and the UAB institutional review board approved all data collection.
Questionnaires
Women were mailed questionnaires on fecal and urinary incontinence before presenting to the Genito-Rectal Disorders Clinic. Demographic information, past medical history, and other potential risk factors for fecal incontinence were collected and entered into an institutional review board-approved database at the time of initial presentation to the clinic. Questionnaires to assess FI included the Modified Manchester Health Questionnaire (MMHQ), which is a validated questionnaire that also includes the Fecal Incontinence Severity Index (FISI). 15, 16 The MMHQ measures health-related quality of life (HR-QOL) for FI and includes 8 subscales on the impact of FI on overall impact, role limitations, physical/social limitations, personal relationships, emotions, sleep/energy, sexual activity, and lifestyle adaptation. The MMHQ is scaled from 0 to 100, for total and subscale scores, where higher scores represent a negative impact on HR-QOL. Women who reported not being currently sexual active did not respond to questions on the impact of FI on this domain, thus only 7 subscales were averaged for the calculation of the total MMHQ score in women who were not sexually active. The FISI measures the frequency of liquid, solid, mucus, or flatal incontinence that occurs from "2 or more times per day," "once per day," "2 or more times per week," "once a week," to "1 to 3 times per month." Patient-weighted scores are used to determine severity and scores range from 0 to 61, with higher scores indicating worse FI severity. 16 A FISI score of 0 indicates continence. Women who responded to any level of flatal incontinence without having incontinence to liquid, solid, or mucous stool were considered incontinent to flatus only and not considered to have fecal incontinence. Only women with incontinence to liquid, solid, or mucous stool were included in this study.
Additional information from the MMHQ that is not used for the total or subscale scores includes questions on bowel movement frequency, fecal urgency, and stool consistency ( Table 1 ). Bowel movement frequency was ascertained by the question, "How often do you move your bowels each day?" Response levels were: "1 to 2 times a day," "3 to 4 times a day," "5 to 6 times a day," "7 or more times a day," "every other day," and "less than every other day." Frequency was then categorized as "Յ every other day," "1 to 2 times a day," and "Ն3 to 4 times a day." Fecal urgency was evaluated by the question, "How often do you have a strong desire to move your bowels which makes you rush to the toilet?" The response levels are: "never," "occasionally," "sometimes," "most of the time," and "all of the time." We defined fecal urgency as occurring "most" or "all of the time" with a strong desire to have a bowel movement and nonurgency as "never," "occasionally," and "sometimes." Stool consistency was characterized by the questions: "What percent of your bowel movements are hard or little balls?" and "What percent of your bowel movements are loose or watery?" Women responded to categories ranging from zero to 100%. Stool consistency was then categorized as occurring Ն50% or Ͻ50% for hard/little balls and for loose/watery stool.
A modified Sandvik Severity Index was used to describe urine leakage as present or absent. 17 The Medical, Epidemiologic, and Social Aspects of Aging (MESA) questionnaire was used to evaluate symptoms of urinary incontinence (UI). 18 The MESA questionnaire has 2 subscales: one for stress urinary incontinence symptoms and one for urge urinary incontinence symptoms. Questions referring to loss of urine at times of exertion such as laughing, sneezing, lifting, or bending define symptoms of stress urinary incontinence. Questions referring to urine loss preceded by an urge to void, or uncontrollable voiding with little or no warning, define symptoms of urge incontinence. The questionnaire has a range of scores from 0 to 27 for stress UI symptoms and from 0 to 18 for urge UI symptoms. Higher scores represent greater symptom severity.
Women also completed the Medical Outcomes Study Short Form 12 (SF-12), a generic health-related quality of life questionnaire. 19 For this analysis, the scales of the SF-12 included the mental and physical component summary scores. For the MMHQ, a higher score indicates worse symptom bother or a negative impact of symptoms on daily functioning. 15 For the scales of the SF-12, a higher DISEASES OF THE COLON & RECTUM VOLUME 53: 8 (2010) score indicates a positive impact on health-related quality of life.
Clinical Evaluation with Anorectal Manometry and Endoanal Ultrasound
Anorectal manometry was completed by physicians using a water-perfused disposable catheter system (Medtronic Inc, Minneapolis, MN). Pressures were recorded during resting, squeezing, and pushing at 1-cm intervals starting at 5 to 6 cm from the anal verge. Maximum tolerated rectal volume was measured in milliliters using an air-filled balloon. To evaluate for tears or disruption of the internal and external anal sphincters, endoanal ultrasound using a 10-MHz, 360°window endoanal probe at 5-mm intervals (B & K Medical Systems Inc, Wilmington, MA) was completed. Women who had scarring of the external anal sphincter were also documented, but not included in the sphincter tear group.
Data Analysis
Pearson correlation coefficient was calculated between FISI scores and MMHQ scores. The relationship with all potential variables and the change in MMHQ scores was evaluated with one-way ANOVA, where a positive change represents an increase in MMHQ score (negative impact on quality of life), and a negative change represents a decline in MMHQ score (positive impact on quality of life). Data are presented as coefficients with 95% CIs. To explore those factors that may impact differences in HR-QOL observed in women seeking treatment for FI, a step-wise linear regression model controlling for FI severity and comorbid disorders with significant differences (P Ͻ .1) on univariate analyses was constructed. Software used for analyses was STATA 8.2 (College Station, TX).
RESULTS
Our cohort included 164 women seeking evaluation for a primary symptom of FI. A subset of women (155/164, 95%) had complete data on the MMHQ. Age ranged from 21 to 85 years (mean age Ϯ SD was 58.7 Ϯ 11.5 years). The sample was predominantly non-Hispanic white participants (88%), with 9% black, 2% Asian American, and 1% self-reported as "other." Table 2 displays clinical characteristics of participants (n ϭ 155) and relationship with MMHQ scores. Younger women were more likely to have higher MMHQ scores (representing a negative impact on HR-QOL). When dichotomizing age, women Ͻ65 years of age had 15-point higher MMHQ scores than women Ն65 years of age. Other variables found to increase MMHQ scores (P Յ .05) were the presence of urinary incontinence (with increasing stress and urge symptoms), prior cholecystectomy, and prior hysterectomy.
In terms of QOL, mean SF-12 physical and mental scores were 39.0 Ϯ 5.7 and 39.1 Ϯ 5.8, respectively, with a weak correlation seen with FISI scores (R 2 ϽϪ0.1 for Anorectal manometry and endoanal ultrasound were performed in a subset of the women presenting for FI treatment, 77% and 86%, respectively ( Table 2) . No significant changes in MMHQ scores were observed when evaluating objective measures such as anorectal manometry pressures and capacity. Although women who had a tear on endoanal ultrasound in either the external or internal anal sphincters had increased MMHQ scores, this relationship was not significant.
After controlling for age, comorbid disease, and FI severity in the linear regression model (Table 3) , women reporting strong urgency symptoms had a 15-point higher MMHQ score (95% CI, 8 -21) . Women with hard stools or little balls Ն50% of the time had a 10-point increase in MMHQ scores. In multivariable analysis, loose or watery stool consistency was not a significant factor for increased MMHQ scores (P ϭ .09) and had no interaction with urgency symptoms. Having undergone a hysterectomy was associated with a 9-point increase in MMHQ scores (95% CI, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . The decrease in MMHQ scores seen in older women remained significant after controlling for other 
DISCUSSION
Even after controlling for age and comorbid diseases in this clinical cohort of women presenting for FI treatment, we found that bowel urgency symptoms, hard stool consistency, and having undergone a hysterectomy remained significant independent predictors of impaired HR-QOL. Although anal sphincter injury resulting from vaginal delivery is viewed as an important factor with regard to FI severity and QOL, 20 we found that bowel urgency and hard stool consistency had a greater negative impact on HR-QOL and deserve more attention from both a future research standpoint, and clinically, with assessment and treatment of FI.
Other studies have also found that bowel urgency and stool consistency are associated with FI in communitydwelling women, 2,11,21 but very few studies have examined the effect of bowel symptoms on HR-QOL in women with FI. 13 In one study that evaluated the impact of FI on HR-QOL in 157 patients attending urogynecology and colorectal clinics for various problems, increased bowel frequency and the amount of soiling had a negative impact on the Fecal Incontinence Quality of Life (FIQL) scale. 13 Other studies have evaluated the impact of bowel symptoms on the presence of FI. In one such study, by Bharucha et al, rectal urgency and symptoms of incomplete evacuation were independent risk factors for FI using a mailed bowel symptoms questionnaire among community-dwelling women. 21 In addition to fecal urgency, stool consistency plays an important role in FI and may impact fecal urgency. National data from the National Health and Nutritional Examination Survey (NHANES) from 2005 to 2006 found that advancing age, loose or watery stools, increased stool frequency, multiple chronic illnesses, and urinary incontinence were independent risk factors for FI in women, but this study did not assess symptoms of rectal urgency or the impact of bowel symptoms on QOL. 8 Although we did not use a validated measure to assess stool consistency, we did address the impact of stool consistency on QOL as measured by MMHQ questions. These findings may have important implications when doing FI intervention trials on modifiable risk factors and evaluating outcomes associated with HR-QOL.
Our study adds to the current literature on HR-QOL in women with FI by further evaluating and controlling for comorbid conditions and FI severity, which are independent risk factors for FI in other studies and may also negatively impact QOL. In one other study that looked at the impact of increased FI severity on HR-QOL on the FIQL scale, the authors found a weak linear correlation (R 2 Յ 0.4) with FI severity (FISI scores) and general QOL as measured by the SF-36 (R 2 Յ 0.1). 22 The lack of correlation of the FISI scores and the FIQL scale may be due to the scoring of the FIQL scale into 4 different domains, whereas the MMHQ is scored from zero to 100 for a total score, and has 8 subscales. In this study, we found a moderate correlation (R 2 ϭ 0.6) for increasing FI severity and a negative impact on HR-QOL. We also found a weak correlation of the SF-12 subscales with the MMHQ scores (R 2 Յ 0.1). Other studies using different measures of FI severity and HR-QOL have found that increasing FI frequency is associated with a negative impact on QOL. 5, 23 More exploration is needed for existing measures of FI severity and HR-QOL, especially in terms of the minimal important difference needed to power future intervention studies for FI treatment.
Interestingly, we found that hard stool consistency had a greater negative impact on HR-QOL than liquid stool consistency. As a limitation of this study, the evaluation of stool consistency was ascertained from a question on the MMHQ (Table 1) and not from the validated Bristol Stool Form Scale. 24 Others have noted that FI to liquid stool had a greater negative impact on general QOL (SF-36 scores) than solid stool FI. 11 But, these studies did not address overall stool consistency in terms of diarrhea or constipation, but looked at only the type of FI as liquid or solid stool loss. 11 Severe constipation and FI were found to have the greatest negative impact on QOL in a study that compared QOL among benign anorectal disorders. 25 Having undergone a hysterectomy had a significant negative impact on HR-QOL. Unfortunately, we did not collect information on menopausal status or the use of hormones to explore the role of hormonal status related to prior hysterectomy and the differential impact of each on HR-QOL. One small randomized controlled trial looked at changes in FI symptoms after administration of estrogen cream and did not find an improvement in FI. 26 Others have evaluated the presence of estrogen receptors in the anorectal canal with mixed findings. 27 More data are needed to evaluate the impact of menopause and hormonal changes on FI in women.
Little is known about the age-related differences on HR-QOL in women with FI. In a study by Wang et al, older women with FI were more likely to have a negative impact on HR-QOL than the younger women, but these findings were not adjusted for obstetric factors. 12 It is possible that women 65 years and older were less likely to report an overall negative impact on HR-QOL than the younger women because of differences in the type of treatment sought for FI. Younger women may have been more likely to report and to seek treatment for their FI symptoms in this cohort. Older women may have been more likely to adapt to their FI symptoms with protective undergarments, and to limit social interactions and travel outside the home. The MMHQ subscales do try to address these adaptive behaviors for women with FI, and no significant differences were seen according to age in the lifestyle adaptation subscale of this instrument (data not shown).
Our study has a few other limitations that deserve further discussion. The main limitations of our study lie in its retrospective nature and the potential for missing data. Although data were collected prospectively, missing data were obtained through a retrospective chart review. We also had limited obstetric data for instrumented deliveries. Other limitations of this single-site study were that the makeup of our patient population was nearly 90% white and there was a potential for referral bias, limiting the generalizability of our results. Strengths of our study include the characterization of the patient population, the use of validated instruments to assess FI severity and HR-QOL, and physiological testing with anorectal manometry and endoanal ultrasound. We plan to continue to characterize these patients after various treatment modalities to further understand factors that may impact on improvement in symptoms.
CONCLUSIONS
Our study confirms findings of previous research, that bowel symptoms, especially urgency and stool consistency, are important factors when addressing patient-centered outcomes such as QOL for FI. Assessment and treatment of fecal urgency and stool consistency may be important factors to consider when measuring patient-centered outcomes in future FI treatment trials.
